Total Payments
$3,458
2024 Payments
$1,638
Companies
25
Transactions
137
Medicare Patients
775
Medicare Billing
$72,606
Payment Breakdown by Category
Food & Beverage$3,368 (97.4%)
Education$89.99 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,368 | 136 | 97.4% |
| Education | $89.99 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $691.94 | 35 | $0 (2024) |
| Ardelyx, Inc. | $320.77 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $292.11 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $281.71 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $238.58 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $236.54 | 9 | $0 (2024) |
| GENZYME CORPORATION | $210.42 | 8 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $160.70 | 4 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $146.65 | 7 | $0 (2024) |
| Madrigal Pharmaceuticals | $130.49 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,638 | 72 | ABBVIE INC. ($275.61) |
| 2023 | $1,246 | 39 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($193.82) |
| 2022 | $404.78 | 16 | ABBVIE INC. ($234.16) |
| 2021 | $169.42 | 10 | AbbVie Inc. ($135.85) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.52 | General |
| Category: Immunology | ||||||
| 11/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: INFLIXIMAB | ||||||
| 11/14/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $130.49 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Immunology | ||||||
| 11/01/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: GI | ||||||
| 10/28/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: GI | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.68 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $131.41 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $87.12 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Immunology | ||||||
| 08/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 441 | 552 | $192,380 | $38,611 |
| 2022 | 5 | 334 | 408 | $163,164 | $33,995 |
Total Patients
775
Total Services
960
Medicare Billing
$72,606
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 230 | $90,160 | $17,504 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $43,602 | $7,603 | 17.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 66 | $13,860 | $3,489 | 25.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $12,400 | $2,696 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 42 | $11,592 | $2,541 | 21.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 39 | 60 | $6,900 | $1,993 | 28.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $6,468 | $1,275 | 19.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $4,746 | $1,026 | 21.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,652 | $485.30 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 222 | $87,024 | $18,488 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 104 | 104 | $52,728 | $10,981 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 43 | $11,868 | $2,204 | 18.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $8,814 | $1,705 | 19.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 13 | $2,730 | $616.78 | 22.6% |
About Tamiko D'elena, PA-C
Tamiko D'elena, PA-C is a Audiologist healthcare provider based in Johns Creek, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164503108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tamiko D'elena, PA-C has received a total of $3,458 in payments from pharmaceutical and medical device companies, with $1,638 received in 2024. These payments were reported across 137 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,368).
As a Medicare-enrolled provider, D'elena has provided services to 775 Medicare beneficiaries, totaling 960 services with total Medicare billing of $72,606. Data is available for 2 years (2022–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Audiologist
- Other Specialties Physician Assistant
- Location Johns Creek, GA
- Active Since 10/18/2006
- Last Updated 12/03/2014
- Taxonomy Code 231H00000X
- Entity Type Individual
- NPI Number 1164503108
Products in Payments
- DUPIXENT (Biological) $492.13
- IBSRELA (Drug) $320.77
- STELARA (Biological) $219.37
- XIFAXAN (Drug) $213.56
- ENTYVIO (Biological) $211.11
- RINVOQ (Biological) $190.96
- HUMIRA (Biological) $173.22
- TREMFYA (Drug) $168.42
- VOQUEZNA (Drug) $160.70
- ZEPOSIA (Drug) $154.32
- OCALIVA (Drug) $146.65
- MAVYRET (Drug) $130.54
- REZDIFFRA (Drug) $130.49
- SKYRIZI (Biological) $124.23
- TERLIVAZ (Drug) $110.85
- Sucraid (Drug) $80.53
- Linzess (Drug) $69.86
- INTERSTIM (Device) $46.01
- CREON (Drug) $42.79
- ZENPEP (Drug) $39.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.